7Baggers

Catalent, Inc
(NYSE:CTLT) 

CTLT stock logo

Catalent, Inc., together with its subsidiaries, provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide. It operates through four segments: Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Sup...

Founded: 2007
Full Time Employees: 13,900
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
Healthcare
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 
                                              
      net revenue
    		1,023,000,000 1,301,000,000 1,074,000,000 1,024,000,000 982,000,000 1,055,000,000 1,037,000,000 1,149,000,000 1,022,000,000 1,313,000,000 1,273,000,000 1,217,000,000 1,025,000,000 1,188,200,000 1,053,300,000 910,800,000 845,700,000 947,600,000 760,600,000 721,400,000 664,700,000 725,700,000 617,500,000 623,000,000 551,800,000 685,300,000 627,900,000 606,300,000 543,900,000 616,900,000 532,600,000 483,700,000 442,200,000 532,200,000 438,000,000 454,900,000 423,000,000 510,100,000 446,600,000 455,800,000 418,300,000  
      yoy
    		4.18% 23.32% 3.57% -10.88% -3.91% -19.65% -18.54% -5.59% -0.29% 10.50% 20.86% 33.62% 21.20% 25.39% 38.48% 26.25% 27.23% 30.58% 23.17% 15.79% 20.46% 5.90% -1.66% 2.75% 1.45% 11.09% 17.89% 25.35% 23.00% 15.92% 21.60% 6.33% 4.54% 4.33% -1.93% -0.20% 1.12%      
      qoq
    		-21.37% 21.14% 4.88% 4.28% -6.92% 1.74% -9.75% 12.43% -22.16% 3.14% 4.60% 18.73% -13.74% 12.81% 15.65% 7.70% -10.75% 24.59% 5.43% 8.53% -8.41% 17.52% -0.88% 12.90% -19.48% 9.14% 3.56% 11.47% -11.83% 15.83% 10.11% 9.38% -16.91% 21.51% -3.72% 7.54% -17.08% 14.22% -2.02% 8.96%   
      cost of sales
    		842,000,000 917,000,000 845,000,000 853,000,000 813,000,000 840,000,000 857,000,000 762,000,000 764,000,000 825,000,000 850,000,000 812,000,000 701,000,000 748,900,000 687,700,000 612,600,000 596,800,000 613,000,000 521,800,000 489,200,000 487,000,000 469,200,000 418,800,000 421,600,000 403,300,000 451,900,000 436,200,000 418,900,000 403,800,000 401,700,000 365,200,000 335,800,000 318,100,000 344,400,000 311,800,000 302,800,000 301,500,000 328,400,000 294,400,000 299,700,000 293,000,000  
      gross margin
    		181,000,000 384,000,000 229,000,000 171,000,000 169,000,000 215,000,000 180,000,000 387,000,000 258,000,000 488,000,000 423,000,000 405,000,000 324,000,000 439,300,000 365,600,000 298,200,000 248,900,000 334,600,000 238,800,000 232,200,000 177,700,000 256,500,000 198,700,000 201,400,000 148,500,000 233,400,000 191,700,000 187,400,000 140,100,000 215,200,000 167,400,000 147,900,000 124,100,000 187,800,000 126,200,000 152,100,000 121,500,000 181,700,000 152,200,000 156,100,000 125,300,000  
      yoy
    		7.10% 78.60% 27.22% -55.81% -34.50% -55.94% -57.45% -4.44% -20.37% 11.09% 15.70% 35.81% 30.17% 31.29% 53.10% 28.42% 40.07% 30.45% 20.18% 15.29% 19.66% 9.90% 3.65% 7.47% 6.00% 8.46% 14.52% 26.71% 12.89% 14.59% 32.65% -2.76% 2.14% 3.36% -17.08% -2.56% -3.03%      
      qoq
    		-52.86% 67.69% 33.92% 1.18% -21.40% 19.44% -53.49% 50.00% -47.13% 15.37% 4.44% 25.00% -26.25% 20.16% 22.60% 19.81% -25.61% 40.12% 2.84% 30.67% -30.72% 29.09% -1.34% 35.62% -36.38% 21.75% 2.29% 33.76% -34.90% 28.55% 13.18% 19.18% -33.92% 48.81% -17.03% 25.19% -33.13% 19.38% -2.50% 24.58%   
      gross margin %
    		17.69% 29.52% 21.32% 16.70% 17.21% 20.38% 17.36% 33.68% 25.24% 37.17% 33.23% 33.28% 31.61% 36.97% 34.71% 32.74% 29.43% 35.31% 31.40% 32.19% 26.73% 35.35% 32.18% 32.33% 26.91% 34.06% 30.53% 30.91% 25.76% 34.88% 31.43% 30.58% 28.06% 35.29% 28.81% 33.44% 28.72% 35.62% 34.08% 34.25% 29.95%  
      selling, general, and administrative expenses
    		252,000,000 266,000,000 214,000,000 250,000,000 205,000,000 217,000,000 190,000,000 226,000,000 196,000,000 226,000,000 207,000,000 228,000,000 183,000,000 184,100,000 172,700,000 165,500,000 164,700,000 158,000,000 136,100,000 141,000,000 142,800,000 143,400,000 129,900,000 123,200,000 115,500,000 124,300,000 117,000,000                
      gain on sale of subsidiary
    		-17,000,000         -250,000   -1,000,000                              
      goodwill impairment charges
    		    689,000,000  210,000,000                                    
      other operating expense
    		13,000,000 12,000,000 32,000,000 35,000,000 1,000,000 124,000,000 15,000,000 23,000,000 2,000,000 16,000,000 5,000,000 16,000,000 4,000,000                              
      operating income
    		-67,000,000 -213,750,000 -17,000,000                                        
      yoy
    		                                          
      qoq
    		-68.65% 1157.35%                                         
      operating margin %
    		-6.55% -16.43% -1.58% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%  
      interest expense
    		60,000,000 65,000,000 65,000,000 66,000,000 58,000,000 56,000,000 51,000,000 47,000,000 32,000,000 32,000,000 33,000,000 32,000,000 26,000,000 31,900,000 26,900,000 25,900,000 25,300,000 20,500,000 34,400,000 34,900,000 36,300,000 30,900,000 26,400,000 25,500,000 28,100,000 30,000,000 29,900,000 27,200,000 24,300,000 22,600,000 22,600,000 22,800,000 22,100,000 21,800,000 21,700,000 22,300,000 22,700,000 22,600,000 23,000,000 23,900,000 35,500,000  
      other income
    		-10,000,000 3,000,000 4,000,000 4,000,000 13,000,000 -5,000,000 -4,000,000 -23,000,000 25,000,000 3,000,000 2,000,000 14,000,000 9,000,000 -2,100,000 24,600,000 -8,300,000        1,400,000                   
      income before income taxes
    		-117,000,000 -266,250,000 -86,000,000                                        
      income tax benefit
    		12,000,000 15,000,000 15,000,000 24,000,000         10,000,000    -15,000,000                          
      net income
    		-129,000,000 23,000,000 -101,000,000 -206,000,000 -759,000,000 -110,000,000 -227,000,000 81,000,000  188,000,000 141,000,000 97,000,000 93,000,000 182,400,000 231,800,000 88,400,000 82,400,000 154,200,000 20,900,000 45,500,000  71,100,000 31,700,000   82,700,000 19,000,000  3,800,000 61,800,000 26,000,000 17,400,000 4,600,000 61,900,000 9,800,000 30,600,000       
      yoy
    		-83.00% -120.91% -55.51% -354.32% NaN% -158.51% -260.99% -16.49% NaN% 3.07% -39.17% 9.73% 12.86% 18.29% 1009.09% 94.29%  116.88% -34.07%   -14.03% 66.84%   33.82% -26.92%  -17.39% -0.16% 165.31% -43.14%           
      qoq
    		-660.87% -122.77% -50.97% -72.86% 590.00% -51.54% -380.25% NaN% NaN% 33.33% 45.36% 4.30% -49.01% -21.31% 162.22% 7.28% -46.56% 637.80% -54.07%   124.29%    335.26%   -93.85% 137.69% 49.43% 278.26% -92.57% 531.63% -67.97%        
      net income margin %
    		-12.61% 1.77% -9.40% -20.12% -77.29% -10.43% -21.89% 7.05% NaN% 14.32% 11.08% 7.97% 9.07% 15.35% 22.01% 9.71% 9.74% 16.27% 2.75% 6.31% 0% 9.80% 5.13% 0% 0% 12.07% 3.03% 0% 0.70% 10.02% 4.88% 3.60% 1.04% 11.63% 2.24% 6.73% 0% 0% 0% 0% 0%  
      earnings per share:
    		                                          
      basic
    		                                          
      diluted
    		                                          
      goodwill impairment (adjustments) charges
    		   -2,000,000                                       
      operating earnings
    		   -112,000,000 -726,000,000 -126,000,000 -235,000,000 138,000,000 60,000,000 246,000,000 211,000,000 161,000,000 138,000,000 251,300,000 368,600,000 126,600,000 81,500,000 170,200,000 100,800,000 89,000,000 34,400,000 109,500,000 65,800,000 78,200,000 20,400,000 97,300,000 73,100,000 68,800,000 31,900,000 96,900,000 64,600,000 47,900,000 24,800,000 31,800,000 31,500,000 58,600,000       
      earnings before income taxes
    		   -182,000,000 -797,000,000 -177,000,000 -282,000,000 114,000,000 3,000,000 211,000,000 176,000,000 115,000,000 103,000,000 221,500,000 317,100,000 109,000,000                           
      income tax (benefit) expense
    		    -38,000,000 -67,000,000 -55,000,000                                    
      less: net earnings attributable to preferred shareholders
    		         -1,000,000  -4,000,000 -9,000,000 -13,500,000 -14,700,000 -11,800,000 -13,600,000 -19,900,000 -9,100,000 -11,200,000                       
      net earnings attributable to common shareholders
    		     -110,000,000 -227,000,000 81,000,000  187,000,000 141,000,000 93,000,000 84,000,000 168,900,000 217,100,000 76,600,000  134,300,000 11,800,000 34,300,000                       
      income tax expense
    		       33,000,000 3,000,000 23,000,000 35,000,000 18,000,000  39,100,000 85,300,000 20,600,000  24,800,000 8,800,000 13,000,000  8,700,000 10,900,000 2,300,000  6,700,000 13,700,000 49,900,000  4,600,000 8,700,000            
      impairment charges and (gain) loss on sale of assets
    		             1,925,000 5,300,000 600,000                           
      restructuring and other costs
    		             2,350,000 3,000,000                            
      (gain) loss on sale of subsidiary
    		             2,000,000 -184,000,000                            
      restructuring and other
    		               5,500,000 900,000 3,000,000 1,300,000 500,000 700,000 1,200,000 3,100,000 100,000 9,700,000 7,500,000 1,400,000 100,000 1,200,000 3,500,000 100,000 3,300,000 1,100,000 5,600,000 1,800,000 600,000 1,000,000 4,700,000 5,200,000 2,100,000 1,400,000  
      impairment charges and (gain)/loss on sale of assets
    		                1,800,000 525,000 600,000 1,700,000 -200,000 675,000 -100,000 -100,000 2,900,000 4,300,000 200,000 4,200,000  7,500,000 1,800,000 500,000  1,900,000 -300,000 -100,000 1,200,000 900,000 300,000 3,500,000   
      other (income)/expense
    		                -11,200,000 9,300,000 36,700,000 -4,400,000 4,900,000 975,000 -3,200,000       5,100,000 7,300,000 -1,800,000 -2,100,000 -8,500,000 -4,200,000 -3,500,000 600,000 3,900,000 800,000 -3,600,000 41,300,000  
      earnings/(loss) before income taxes
    		                67,400,000                          
      net earnings/(loss) attributable to common shareholders
    		                68,800,000    -8,000,000                      
      earnings per share:
    		                                          
      basic
    		                                          
      net earnings/
    		                0.42    100,000   49,000,000 -14,400,000   -21,900,000      0.1 0.08 0.25 8,900,000 153,400,000 30,800,000 46,000,000 -19,900,000  
      diluted
    		                                          
      earnings from operations before income taxes
    		                 20,350,000 29,700,000 58,500,000                       
      earnings/(loss) from operations before income taxes
    		                    -6,800,000                      
      income tax expense/
    		                    -6,900,000    1,000,000    -1,900,000   9,500,000 200,000 15,400,000 4,200,000 9,200,000 4,900,000 -90,800,000 11,200,000 -4,100,000 -14,000,000  
      net earnings/
    		                0.42    100,000   49,000,000 -14,400,000   -21,900,000      0.1 0.08 0.25 8,900,000 153,400,000 30,800,000 46,000,000 -19,900,000  
      less: series a preferred stock dividend
    		                    -8,100,000                      
      earnings/(loss) per share:
    		                                          
      basic
    		                                          
      diluted
    		                                          
      earnings from continuing operations before income taxes
    		                     20,125,000 42,600,000 51,300,000        26,900,000 4,800,000 77,300,000 14,000,000 39,800,000       
      other income/(income)
    		                        5,700,000 7,450,000 10,500,000 13,600,000 5,700,000              
      earnings/(loss) from operations, before income taxes
    		                        -13,400,000                  
      earnings from continuing operations, before income taxes
    		                         15,650,000 32,700,000 28,000,000 1,900,000 16,600,000 34,700,000            
      selling, general and administrative expenses
    		                           114,300,000 107,000,000 107,300,000 100,900,000 96,200,000 98,200,000 89,700,000 93,200,000 93,000,000 82,200,000 86,900,000 80,900,000 88,100,000 81,400,000  
      less: net (loss) attributable to noncontrolling interest, net of tax
    		                                   -100,000       
      net earnings attributable to catalent
    		                             61,800,000 26,000,000 17,400,000 4,600,000 61,900,000 9,800,000 30,700,000       
      earnings per share attributable to catalent:
    		                                          
      basic
    		                                          
      diluted
    		                                          
      amounts attributable to catalent:
    		                                          
      earnings from continuing operations
    		                                4,600,000 61,900,000 9,800,000 30,600,000       
      net earnings/(loss) from discontinued operations, net of tax
    		                                     -100,000  -200,000 400,000  
      earnings from continuing operations less net (loss) attributable to noncontrolling interest
    		                                4,600,000 12,400,000 9,800,000 30,700,000       
      earnings per share attributable to catalent:
    		                                          
      basic
    		                                          
      diluted
    		                                          
      earnings per share attributable to catalent:
    		                                          
      basic
    		                                          
      earnings/(loss) from continuing operations
    		                                 0.1 0.08 0.25 8,900,000 153,500,000 30,800,000 46,200,000 -20,300,000  
      net earnings/
    		                0.42    100,000   49,000,000 -14,400,000   -21,900,000      0.1 0.08 0.25 8,900,000 153,400,000 30,800,000 46,000,000 -19,900,000  
      diluted
    		                                          
      operating earnings/
    		                                    37,100,000 89,200,000 65,800,000 62,400,000 42,500,000  
      earnings/(loss) from continuing operations before income taxes
    		                                    13,800,000 62,700,000 42,000,000 42,100,000 -34,300,000  
      less: net earnings/(loss) attributable to noncontrolling interest, net of tax
    		                                    -200,000 -300,000 -700,000 -500,000 -400,000  
      net earnings/(loss) attributable to catalent
    		                                    9,100,000 153,700,000 31,500,000 46,500,000 -19,500,000  
      earnings/(loss) from continuing operations less net earnings attributable to noncontrolling interest
    		                                    9,100,000 14,575,000 31,500,000 46,700,000   
      earnings per share attributable to catalent:
    		                                          
      basic
    		                                          
      diluted
    		                                          
      earnings/(loss) from continuing operations less net income attributable to noncontrolling interest
    		                                        -19,900,000  
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 
                                                
        assets
      		                                          
        current assets:
      		                                          
        cash and cash equivalents
      		335,000,000 289,000,000 162,000,000 229,000,000 209,000,000 280,000,000 252,000,000 442,000,000 281,000,000 449,000,000 786,000,000 849,000,000 1,969,000,000 896,000,000 988,100,000 833,100,000 1,007,000,000 953,200,000 608,400,000 188,900,000 243,400,000 345,400,000 227,900,000 207,900,000 266,100,000 410,200,000 391,500,000 329,500,000 601,400,000 288,300,000 241,200,000 255,800,000 132,100,000 131,600,000 133,900,000 115,500,000 151,400,000 151,300,000 116,100,000 84,100,000 63,200,000 74,400,000 
        trade receivables, net of allowance
      		760,000,000 921,000,000 875,000,000 843,000,000 830,000,000 1,002,000,000 1,049,000,000 916,000,000 989,000,000 1,051,000,000 932,000,000 871,000,000 831,000,000 1,012,000,000                             
        inventories
      		553,000,000 574,000,000 742,000,000 775,000,000 796,000,000 777,000,000 744,000,000 818,000,000 732,000,000 702,000,000 676,000,000 688,000,000 622,000,000 563,000,000 527,900,000 461,300,000 384,300,000 323,800,000 297,200,000 249,600,000 250,700,000 257,200,000 247,000,000 235,200,000 235,800,000 209,100,000 223,600,000 212,700,000 194,000,000 184,900,000 193,900,000 169,800,000 177,500,000 154,800,000 167,700,000 159,300,000 150,900,000 132,900,000 142,200,000 144,300,000 142,400,000 134,800,000 
        prepaid expenses and other current assets
      		859,000,000 813,000,000                                         
        total current assets
      		2,507,000,000 2,597,000,000 2,523,000,000 2,570,000,000 2,614,000,000 2,692,000,000 2,738,000,000 2,918,000,000 2,698,000,000 2,916,000,000 3,025,000,000 2,974,000,000 3,931,000,000 2,918,000,000 2,774,500,000 2,518,900,000 2,356,100,000 2,293,000,000 1,746,100,000 1,300,500,000 1,266,800,000 1,395,800,000 1,143,700,000 1,071,500,000 1,083,400,000 1,240,300,000 1,214,400,000 1,075,500,000 1,330,100,000 1,059,800,000 928,400,000 882,600,000 768,900,000 790,200,000 727,500,000 679,500,000 691,200,000 737,500,000 653,100,000 637,500,000 619,100,000 687,500,000 
        property, plant, and equipment, net of accumulated depreciation of 1,983 and 1,915, respectively
      		3,671,000,000                                          
        other assets:
      		                                          
        goodwill
      		2,366,000,000 2,333,000,000 2,339,000,000 2,351,000,000 2,316,000,000 3,039,000,000 3,023,000,000 3,215,000,000 2,929,000,000 3,006,000,000 3,012,000,000 3,026,000,000 2,531,000,000 2,519,000,000 2,515,000,000 2,461,500,000 2,490,400,000 2,470,600,000 2,449,300,000 2,207,800,000 2,195,900,000 2,220,900,000 1,409,300,000 1,421,400,000 1,435,000,000 1,397,200,000 1,438,600,000 1,408,300,000 1,069,600,000 1,044,100,000 1,030,600,000 1,008,500,000 1,045,400,000 996,500,000 1,020,300,000 1,027,200,000 1,038,100,000 1,061,500,000 1,039,900,000 1,082,400,000 1,057,900,000 1,097,100,000 
        other intangibles
      		811,000,000 841,000,000 875,000,000 911,000,000 942,000,000 980,000,000 1,012,000,000 1,045,000,000 1,017,000,000 1,060,000,000 1,097,000,000 1,132,000,000 793,000,000 817,000,000 834,800,000 855,300,000 870,300,000 888,700,000 907,300,000 885,900,000 902,900,000 930,800,000 554,400,000 581,000,000 611,900,000 544,900,000 572,200,000 582,000,000 269,200,000 273,100,000 282,600,000 283,900,000 306,100,000 294,000,000 316,300,000 332,700,000 348,100,000 368,700,000 373,600,000 392,700,000 360,900,000 357,600,000 
        deferred income taxes
      		32,000,000 7,000,000 66,000,000 55,000,000 100,000,000 55,000,000 42,000,000 55,000,000 45,000,000 49,000,000 68,000,000 65,000,000 70,000,000 66,000,000 44,100,000 44,600,000 57,100,000 49,400,000 45,100,000 35,100,000 34,100,000 38,600,000 30,100,000 31,700,000 33,800,000 32,900,000 26,900,000 34,300,000 62,600,000 53,900,000 53,000,000 51,200,000 59,600,000 37,500,000 65,800,000 66,100,000 67,500,000 64,100,000 32,000,000 30,900,000 24,400,000 26,300,000 
        other long-term assets
      		321,000,000 332,000,000 341,000,000 324,000,000 328,000,000 329,000,000 344,000,000 335,000,000 349,000,000 349,000,000 300,000,000 279,000,000 277,000,000 268,000,000 241,900,000 188,000,000                           
        total assets
      		9,708,000,000 9,753,000,000 9,879,000,000 9,988,000,000 10,023,000,000 10,777,000,000 10,830,000,000 11,147,000,000 10,205,000,000 10,507,000,000 10,322,000,000 10,203,000,000 10,183,000,000 9,112,000,000 8,769,100,000 8,198,100,000 7,984,200,000 7,776,500,000 7,079,600,000 6,195,300,000 6,119,500,000 6,184,000,000 4,493,100,000 4,441,600,000 4,499,800,000 4,531,100,000 4,554,100,000 4,387,100,000 3,784,800,000 3,454,300,000 3,285,200,000 3,154,300,000 3,128,100,000 3,091,100,000 3,057,700,000 3,035,200,000 3,056,400,000 3,145,400,000 2,974,100,000 3,038,100,000 2,951,300,000 3,090,200,000 
        liabilities and shareholders' equity
      		                                          
        current liabilities:
      		                                          
        current portion of long-term obligations and other short-term borrowings
      		48,000,000 48,000,000 47,000,000 46,000,000 624,000,000 536,000,000 588,000,000 632,000,000 106,000,000 31,000,000 29,000,000 29,000,000 79,000,000 75,000,000 73,600,000 72,000,000 73,400,000 72,900,000 271,800,000 72,400,000 74,300,000 76,500,000 70,300,000 69,900,000 73,400,000 71,900,000 70,600,000 69,900,000 23,900,000 24,600,000 23,700,000 23,100,000 99,300,000 27,700,000 25,900,000 24,400,000 24,000,000 23,800,000 24,800,000 28,800,000 36,400,000 25,200,000 
        accounts payable
      		375,000,000 361,000,000 377,000,000 407,000,000 367,000,000 424,000,000 394,000,000 367,000,000 379,000,000 421,000,000 401,000,000 363,000,000 363,000,000 385,000,000 365,700,000 356,900,000 329,400,000 321,000,000 276,200,000 243,400,000 214,000,000 255,800,000 202,300,000 184,400,000 180,100,000 192,100,000 182,900,000 164,300,000 166,800,000 163,200,000 137,600,000 127,600,000 145,700,000 143,700,000 135,100,000 128,500,000 127,400,000 128,200,000 120,900,000 118,400,000 116,700,000 148,100,000 
        other accrued liabilities
      		575,000,000 622,000,000 583,000,000 583,000,000 543,000,000 570,000,000 505,000,000 527,000,000 458,000,000 620,000,000 616,000,000 653,000,000 654,000,000 736,000,000 699,900,000 595,100,000 516,900,000 499,300,000 369,100,000 342,300,000 327,500,000 338,400,000 252,800,000 260,000,000 274,000,000 312,900,000 304,000,000 249,800,000 266,400,000 281,200,000 228,800,000 184,100,000 203,600,000 219,800,000 210,500,000 187,300,000 201,500,000 247,000,000 219,700,000 199,300,000 224,500,000 279,700,000 
        total current liabilities
      		998,000,000 1,031,000,000 1,007,000,000 1,036,000,000 1,534,000,000 1,530,000,000 1,487,000,000 1,526,000,000 943,000,000 1,072,000,000 1,046,000,000 1,045,000,000 1,096,000,000 1,196,000,000 1,139,200,000 1,024,000,000 919,700,000 893,200,000 917,100,000 658,100,000 615,800,000 670,700,000 525,400,000 514,300,000 527,500,000 576,900,000 557,500,000 484,000,000 457,100,000 469,000,000 390,100,000 334,800,000 448,600,000 391,200,000 371,500,000 340,200,000 352,900,000 399,000,000 365,400,000 346,500,000 377,600,000 453,000,000 
        long-term obligations, less current portion
      		4,886,000,000 4,857,000,000 4,933,000,000 4,959,000,000 4,322,000,000 4,313,000,000 4,261,000,000 4,221,000,000 4,098,000,000 4,171,000,000 4,157,000,000 4,191,000,000 4,225,000,000 3,166,000,000 3,149,600,000 2,983,800,000 2,985,300,000 2,945,100,000 2,926,900,000 2,824,600,000 2,858,700,000 2,882,800,000 2,116,300,000 2,130,000,000 2,205,700,000 2,649,400,000 2,706,500,000 2,672,500,000 2,082,900,000 2,055,100,000 2,025,300,000 2,001,300,000 1,838,000,000 1,832,800,000 1,844,900,000 1,848,300,000 1,859,900,000 1,864,100,000 1,857,000,000 1,905,400,000 1,780,300,000 2,685,400,000 
        pension liability
      		96,000,000 95,000,000 97,000,000 101,000,000 99,000,000 100,000,000 104,000,000 103,000,000 98,000,000 103,000,000 122,000,000 127,000,000 133,000,000 137,000,000 140,000,000 141,900,000 135,500,000 135,200,000 137,600,000 138,400,000 139,600,000 143,600,000 128,500,000 129,600,000 132,100,000 131,600,000 128,000,000 127,300,000 129,300,000 129,500,000 141,500,000 141,000,000 149,800,000 151,000,000 138,500,000 138,900,000 141,800,000 143,700,000 133,900,000 143,400,000 148,100,000 154,700,000 
        other long-term liabilities
      		164,000,000 161,000,000                                         
        total liabilities
      		6,166,000,000 6,149,000,000 6,268,000,000 6,301,000,000 6,182,000,000 6,166,000,000 6,127,000,000 6,235,000,000 5,505,000,000 5,712,000,000 5,690,000,000 5,722,000,000 5,803,000,000 4,838,000,000 4,696,900,000 4,383,600,000 4,305,500,000 4,271,100,000 4,285,300,000 3,872,600,000 3,863,600,000 3,895,800,000                     
        commitment and contingencies
      		                                          
        shareholders’ equity:
      		                                          
        common stock, 0.01 par value...
      		2,000,000 2,000,000 2,000,000 2,000,000 2,000,000 2,000,000 2,000,000 2,000,000 2,000,000 2,000,000 2,000,000 2,000,000 2,000,000 2,000,000 1,700,000 1,700,000 1,600,000 1,600,000 1,500,000 1,500,000 1,500,000 1,500,000                     
        preferred stock, 0.01 par value...
      		                                          
        additional paid in capital
      		4,800,000,000 4,787,000,000 4,769,000,000 4,742,000,000 4,724,000,000 4,701,000,000 4,697,000,000 4,686,000,000 4,674,000,000 4,649,000,000 4,630,000,000 4,615,000,000 4,234,000,000 4,205,000,000 4,185,700,000 4,160,800,000 3,901,400,000 3,818,700,000 3,261,000,000 2,759,200,000 2,755,200,000 2,757,400,000 2,739,200,000 2,735,100,000 2,733,600,000 2,283,300,000 2,277,500,000 2,272,900,000 2,268,400,000 1,992,000,000 1,990,100,000 1,987,800,000 1,983,300,000 1,976,500,000 1,973,900,000 1,972,900,000 1,970,400,000 1,973,700,000 1,974,200,000 1,981,100,000 1,979,000,000 1,031,400,000 
        accumulated deficit
      		-910,000,000              -150,300,000 -377,400,000 -460,900,000 -535,200,000 -681,200,000 -694,000,000 -731,400,000 -723,400,000 -790,700,000 -822,400,000 -871,400,000 -872,100,000 -954,800,000 -973,800,000 -951,900,000 -955,700,000 -1,022,300,000 -1,048,300,000 -1,065,700,000 -1,036,100,000 -1,117,300,000 -1,127,100,000 -1,157,800,000 -1,166,900,000 -1,320,600,000 -1,352,100,000 -1,398,600,000 -1,379,100,000 
        accumulated other comprehensive loss
      		-350,000,000 -404,000,000 -356,000,000 -354,000,000 -388,000,000 -354,000,000 -368,000,000 -395,000,000 -514,000,000 -394,000,000 -350,000,000 -345,000,000 -329,000,000 -317,000,000 -323,900,000 -329,600,000 -370,000,000                          
        total shareholders’ equity
      		3,542,000,000 3,604,000,000    4,611,000,000    4,795,000,000    3,915,000,000    2,898,800,000    1,681,600,000    1,086,700,000    723,500,000    635,900,000         
        total liabilities and shareholders’ equity
      		9,708,000,000 9,753,000,000    10,777,000,000                    4,531,100,000                 
        property, plant, and equipment
      		 3,643,000,000    3,682,000,000    3,127,000,000    2,524,000,000 2,358,800,000 2,129,800,000 2,035,500,000 1,900,800,000 1,769,500,000 1,618,100,000 1,561,100,000 1,536,700,000 1,301,500,000 1,285,800,000 1,288,200,000 1,270,600,000 1,271,400,000 1,256,200,000 1,025,000,000 995,900,000 968,900,000 905,000,000 926,500,000 905,800,000 906,300,000 902,000,000 884,300,000 885,200,000 847,300,000 865,100,000 853,300,000 873,000,000 
        liabilities and shareholders’ equity
      		                                          
        (accumulated deficit) retained earnings
      		 -781,000,000 -804,000,000 -703,000,000 -497,000,000                                      
        prepaid expenses and other
      		  744,000,000 723,000,000 779,000,000 633,000,000 693,000,000 714,000,000 632,000,000 625,000,000 537,000,000 500,000,000 459,000,000 376,000,000 348,900,000 453,000,000 263,900,000 177,900,000 141,800,000 181,000,000 124,800,000 76,800,000 85,300,000 77,100,000 78,200,000 65,200,000 92,500,000 105,400,000 124,200,000 97,800,000 90,700,000 90,700,000 83,000,000 89,000,000 82,200,000 72,700,000 80,700,000 80,900,000 63,200,000 72,700,000 81,300,000 74,600,000 
        property, plant, and equipment, net of accumulated depreciation of 1,842 and 1,596, respectively
      		  3,735,000,000                                        
        other liabilities
      		  167,000,000 155,000,000 159,000,000 147,000,000 156,000,000 164,000,000 152,000,000 164,000,000 154,000,000 170,000,000 178,000,000 175,000,000 167,800,000 167,400,000 181,400,000 203,600,000 208,100,000 175,400,000 179,000,000 124,300,000 69,500,000 54,600,000 54,000,000 54,000,000 62,300,000 57,100,000 46,400,000 45,500,000 42,600,000 40,300,000 39,500,000 38,800,000 39,600,000 41,100,000 41,100,000 42,500,000 39,600,000 42,100,000 40,400,000 61,200,000 
        commitments and contingencies
      		                                          
        shareholders' equity:
      		                                          
        total shareholders' equity
      		  3,611,000,000 3,687,000,000 3,841,000,000  4,703,000,000 4,912,000,000 4,700,000,000  4,632,000,000 4,481,000,000 4,021,000,000  3,713,200,000 3,455,500,000 3,072,100,000  2,187,700,000 1,716,100,000 1,649,300,000    1,529,400,000  1,068,400,000 1,005,500,000 1,038,800,000  642,700,000 588,000,000 614,500,000  602,900,000 607,400,000       
        total liabilities and shareholders' equity
      		  9,879,000,000 9,988,000,000 10,023,000,000  10,830,000,000 11,147,000,000 10,205,000,000                4,499,800,000  4,554,100,000 4,387,100,000 3,784,800,000  3,285,200,000 3,154,300,000 3,128,100,000          
        property, plant, and equipment, net of accumulated depreciation of 1,756 and 1,596, respectively
      		   3,777,000,000                                       
        property, plant, and equipment, net of accumulated depreciation of 1,647 and 1,596, respectively
      		    3,723,000,000                                      
        marketable securities
      		       28,000,000 64,000,000 89,000,000 94,000,000 66,000,000 50,000,000 71,000,000 74,700,000                            
        redeemable preferred stock, 0.01 par value...
      		            359,000,000 359,000,000 359,000,000 359,000,000 606,600,000 606,600,000 606,600,000 606,600,000 606,600,000 606,600,000                     
        retained earnings
      		     262,000,000 372,000,000 619,000,000 538,000,000 538,000,000 350,000,000 209,000,000 114,000,000                              
        property, plant, and equipment, net of accumulated depreciation of 1,540 and 1,347, respectively
      		      3,671,000,000                                    
        property, plant, and equipment, net of accumulated depreciation of 1,465 and 1,347, respectively
      		       3,579,000,000                                   
        property, plant, and equipment, net of accumulated depreciation of 1,358 and 1,347, respectively
      		        3,167,000,000                                  
        total liabilities, redeemable preferred stock, and shareholders’ equity
      		         10,507,000,000    9,112,000,000    7,776,500,000    6,184,000,000                     
        property, plant, and equipment, net of accumulated depreciation of 1,308 and 1,179, respectively
      		          2,820,000,000                                
        liabilities, redeemable preferred stock, and shareholders' equity
      		                                          
        total liabilities, redeemable preferred stock, and shareholders' equity
      		          10,322,000,000 10,203,000,000 10,183,000,000  8,769,100,000 8,198,100,000 7,984,200,000  7,079,600,000 6,195,300,000 6,119,500,000                      
        property, plant, and equipment, net of accumulated depreciation of 1,255 and 1,179, respectively
      		           2,727,000,000                               
        property, plant, and equipment, net of accumulated depreciation of 1,215 and 1,179, respectively
      		            2,581,000,000                              
        accumulated earnings
      		             25,000,000                             
        trade receivables
      		              834,900,000 771,500,000 700,900,000 838,100,000 698,700,000 681,000,000 647,900,000 716,400,000 583,500,000 551,300,000 503,300,000 555,800,000 506,800,000 427,900,000 410,500,000 488,800,000 402,600,000 366,300,000 376,300,000 414,800,000 343,700,000 332,000,000 308,200,000 372,400,000 331,600,000 336,400,000 332,200,000 403,700,000 
        other
      		                174,800,000 174,000,000 162,300,000 147,900,000 158,700,000 61,200,000 54,100,000 50,200,000 47,500,000 45,200,000 30,600,000 30,800,000 28,300,000 27,500,000 21,700,000 23,100,000 21,600,000 67,100,000 21,500,000 27,700,000 27,200,000 28,400,000 28,200,000 29,500,000 35,700,000 48,700,000 
        shareholders’ equity/
      		                                          
        accumulated other comprehensive income/
      		                 -386,300,000 -393,600,000 -350,600,000 -376,000,000 -353,900,000 -329,300,000 -351,200,000 -334,200,000 -325,800,000 -255,600,000 -294,900,000 -279,000,000 -314,100,000 -326,300,000 -352,700,000 -304,300,000 -305,700,000 -254,900,000 -239,600,000 -216,600,000 -174,000,000 -186,600,000 -136,900,000 -77,800,000 -24,200,000 
        liabilities and shareholder’s deficit
      		                                          
        common stock 0.01 par value...
      		                      1,500,000 1,500,000 1,400,000 1,300,000 1,300,000 1,300,000 1,300,000 1,300,000 1,200,000 1,200,000 1,200,000 1,200,000 1,200,000 1,200,000 1,200,000 1,200,000 1,200,000 1,200,000 1,200,000 700,000 
        preferred stock 0.01 par value...
      		                                          
        total shareholder's equity
      		                      1,620,700,000 1,563,000,000                   
        total liabilities and shareholder’s equity
      		                      4,493,100,000 4,441,600,000                   
        shareholders' equity/
      		                                          
        liabilities, redeemable noncontrolling interest, and shareholders’ equity
      		                                          
        total liabilities, redeemable noncontrolling interest and shareholders’ equity
      		                             3,454,300,000    3,091,100,000         
        redeemable noncontrolling interest
      		                                    5,800,000 5,800,000 4,500,000 3,900,000 4,300,000 4,500,000 
        total catalent shareholders’ equity
      		                                 635,900,000         
        noncontrolling interest
      		                                       -900,000 -800,000 -600,000 
        liabilities, redeemable noncontrolling interest, and shareholders' equity
      		                                          
        total liabilities, redeemable noncontrolling interest and shareholders' equity
      		                                  3,057,700,000 3,035,200,000       
        liabilities, redeemable noncontrolling interest, and shareholders' equity/
      		                                          
        total catalent shareholders' equity/
      		                                    597,200,000  468,200,000 493,300,000 503,800,000 -371,200,000 
        total shareholders' equity/
      		                                    597,200,000  468,200,000 492,400,000 503,000,000  
        total liabilities, redeemable noncontrolling interest and shareholders' equity/
      		                                    3,056,400,000  2,974,100,000 3,038,100,000 2,951,300,000  
        liabilities, redeemable noncontrolling interest, and shareholders’ equity/
      		                                          
        total catalent shareholders’ equity/
      		                                     634,000,000     
        total shareholders’ equity/
      		                                     634,000,000     
        total liabilities, redeemable noncontrolling interest and shareholders’ equity/
      		                                     3,145,400,000     
        liabilities, redeemable noncontrolling interest and shareholders' deficit
      		                                          
        total shareholders' deficit
      		                                         -371,800,000 
        total liabilities, redeemable noncontrolling interest and shareholders' deficit
      		                                         3,090,200,000 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2020-12-31 2020-09-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 
                                               
          cash flows from operating activities:
        		                                       
          net income
        		-129,000,000 23,000,000 -101,000,000 -206,000,000 -759,000,000 -110,000,000 -227,000,000   188,000,000 141,000,000 97,000,000 93,000,000 182,400,000 170,800,000 82,400,000 66,500,000 45,600,000  71,100,000    82,700,000   3,800,000  26,000,000 17,400,000 4,600,000  9,800,000       
          adjustments to reconcile net income to net cash from operations:
        		                                       
          depreciation and amortization
        		113,000,000 130,000,000 126,000,000 121,000,000 112,000,000 114,000,000 106,000,000 103,000,000 99,000,000 100,000,000 99,000,000 98,000,000 81,000,000 73,000,000 140,100,000 69,100,000 187,300,000 122,500,000 60,600,000 54,700,000 66,400,000 54,600,000 52,900,000 52,600,000 51,700,000 46,800,000 39,000,000 38,700,000 36,500,000 35,500,000 35,800,000 35,100,000 34,800,000 35,200,000 35,500,000 36,200,000 34,400,000 35,200,000 35,000,000 
          goodwill impairment charges
        		 0 0 -2,000,000 689,000,000 0                                  
          non-cash foreign currency transaction (gain) loss
        		-10,000,000     -3,000,000       9,000,000  -12,000,000                         
          amortization of debt issuance costs
        		3,000,000  4,000,000 4,000,000 2,000,000  2,000,000 2,000,000 2,000,000  1,000,000 2,000,000 2,000,000                           
          impairments charges and loss/gain on sale of assets
        		4,000,000   15,000,000 -1,000,000  5,000,000 1,000,000 -2,000,000                               
          gain on sale of subsidiary
        		-17,000,000          0 0 -1,000,000                           
          stock-based compensation
        		17,000,000 16,000,000 17,000,000 16,000,000 19,000,000 0 6,000,000 10,000,000 19,000,000 12,000,000 10,000,000 11,000,000 21,000,000 12,500,000 30,100,000      6,600,000 7,500,000 10,000,000                 
          benefit from deferred income taxes
        		-5,000,000  3,000,000 17,000,000 -44,000,000   17,000,000 -4,000,000 1,000,000 12,000,000                             
          benefit from bad debts and inventory
        		39,000,000 -5,000,000 43,000,000 34,000,000 10,000,000 44,000,000 32,000,000 39,000,000 28,000,000 3,000,000 5,000,000 -1,000,000 10,000,000 1,000,000 18,400,000 7,900,000 11,400,000 9,400,000 4,100,000 1,900,000 5,500,000 2,300,000 2,800,000 2,000,000 1,400,000 -1,400,000 4,900,000 5,400,000 2,300,000 1,300,000 2,000,000 5,000,000 1,100,000 6,200,000 900,000 3,200,000 2,300,000 5,500,000 1,700,000 
          change in operating assets and liabilities:
        		                                       
          decrease in trade receivables
        		173,000,000  -35,000,000 5,000,000 160,000,000  -130,000,000 117,000,000 31,000,000   -54,000,000 185,000,000  87,600,000 143,700,000  4,300,000                      
          increase in inventories
        		-10,000,000  -15,000,000 -15,000,000 -31,000,000 -57,000,000 45,000,000 -95,000,000 -85,000,000 -35,000,000 55,000,000 -85,000,000 -63,000,000 -20,000,000 -140,300,000                         
          decrease in accounts payable
        		-10,000,000  -18,000,000 33,000,000 -73,000,000    -52,000,000         -13,300,000                      
          other assets/accrued liabilities, net—current and non-current
        		-107,000,000  -33,000,000 78,000,000 -163,000,000  -64,000,000 -26,000,000 -155,000,000  -79,000,000 -49,000,000 -165,000,000  -68,800,000 -93,400,000 -48,400,000 -49,300,000 -52,700,000                     
          net cash from operating activities
        		61,000,000 214,000,000 12,000,000 112,000,000 -70,000,000 196,000,000 -64,000,000 214,000,000 -92,000,000 69,000,000 138,000,000 69,000,000 163,000,000 134,300,000 223,700,000 149,700,000 267,600,000 145,900,000 25,200,000 87,900,000 75,300,000 43,300,000 41,200,000 103,300,000 95,200,000 92,300,000 83,700,000             
          capital expenditures
        		18,000,000 0 -8,000,000 0 21,000,000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -88,800,000 -48,000,000 -43,000,000 -38,300,000 -58,800,000 -34,800,000 -40,200,000 -42,700,000             
          free cash flows
        		79,000,000 214,000,000 4,000,000 112,000,000 -49,000,000 196,000,000 -64,000,000 214,000,000 -92,000,000 69,000,000 138,000,000 69,000,000 163,000,000 134,300,000 223,700,000 149,700,000 267,600,000 145,900,000 25,200,000 -900,000 27,300,000 300,000 2,900,000 44,500,000 60,400,000 52,100,000 41,000,000             
          cash flows used in investing activities:
        		                                       
          acquisition of property, equipment, and other productive assets
        		-57,000,000  -74,000,000 -94,000,000 -84,000,000  -138,000,000 -168,000,000 -149,000,000  -148,000,000 -123,000,000 -154,000,000  -338,900,000 -149,600,000 -303,500,000 -152,200,000 -73,500,000                     
          proceeds from sale of property and equipment
        		 0 0 0 1,000,000 0 1,000,000 1,000,000 6,000,000      300,000     100,000    0 0   0 -600,000           
          proceeds from sale of subsidiary
        		23,000,000                                       
          payment for investments
        		 1,000,000 0    -1,000,000                                 
          net cash from investing activities
        		-34,000,000 -74,000,000 -74,000,000 -95,000,000 -84,000,000 -121,000,000 -110,000,000 -608,000,000 -116,000,000 -394,000,000 -191,000,000 -1,132,000,000 -167,000,000 -213,100,000 -354,400,000 -151,200,000                        
          cash flows from financing activities:
        		                                       
          proceeds from borrowing
        		    115,000,000  90,000,000 550,000,000 75,000,000    1,096,000,000 -2,600,000   1,109,100,000       0 0   0 0 322,400,000 75,000,000     0 0   
          payments related to long-term obligations
        		-5,000,000  -249,000,000 -687,000,000 -35,000,000  -144,000,000 -25,000,000 -7,000,000 -6,000,000 -8,000,000 -61,000,000 -3,000,000 -12,200,000 -54,800,000 -2,400,000 -808,900,000 -51,500,000 -3,300,000 -782,300,000 -4,600,000 -48,700,000 -454,700,000 -4,700,000 -4,800,000 -4,700,000 -4,700,000 -4,600,000 -4,700,000 -204,500,000 -4,700,000 -4,700,000 -4,600,000 -4,600,000 -4,700,000 -5,000,000 -5,500,000 -5,500,000 -863,800,000 
          financing fees paid
        		 0 0 -15,000,000 -1,000,000 0 0   0 0 0 -15,000,000 -300,000   -25,100,000       0 0    0           
          cash received, in lieu of equity, for tax-withholding obligations
        		1,000,000                                       
          exercise of stock options
        		1,000,000 0 8,000,000 0 1,000,000 0 3,000,000 0 1,000,000 5,000,000 2,000,000 11,000,000 8,000,000 15,900,000                          
          other financing activities
        		-7,000,000 -5,000,000 -4,000,000 -12,000,000 18,000,000 3,000,000 26,000,000 4,000,000 3,000,000 3,000,000 3,000,000 2,000,000 4,000,000 3,800,000 3,700,000                         
          net cash from financing activities
        		-10,000,000 -10,000,000 0 -14,000,000 98,000,000 -51,000,000 -25,000,000 523,000,000 74,000,000 1,000,000 -3,000,000 -49,000,000 1,082,000,000 -17,300,000 -7,200,000          -7,800,000 419,400,000 263,000,000             
          effect of foreign currency exchange on cash and cash equivalents
        		29,000,000  -5,000,000 17,000,000 -15,000,000  9,000,000 32,000,000 -34,000,000  -7,000,000 -8,000,000 -5,000,000                           
          net increase in cash and cash equivalents
        		46,000,000        -168,000,000    1,073,000,000                           
          cash and cash equivalents at beginning of period
        		289,000,000  0 0 280,000,000  0 0 449,000,000  0 0 896,000,000                           
          cash and cash equivalents at end of period
        		335,000,000  -67,000,000 20,000,000 209,000,000  -190,000,000 161,000,000 281,000,000  -63,000,000 -1,120,000,000 1,969,000,000                           
          supplementary cash flow information:
        		                                       
          interest paid
        		68,000,000 44,000,000 70,000,000 47,000,000 65,000,000 43,000,000 62,000,000 37,000,000 46,000,000 23,000,000 43,000,000 10,000,000 40,000,000 8,000,000 52,000,000 43,400,000 88,700,000 47,700,000 24,800,000 27,900,000 22,400,000 22,700,000 29,500,000 26,000,000 15,700,000 24,800,000 16,700,000 26,000,000 15,400,000 19,200,000 20,200,000 19,800,000 21,600,000 20,200,000 20,800,000 20,600,000 19,500,000 22,700,000 44,300,000 
          income taxes paid
        		9,000,000 -21,000,000 33,000,000 12,000,000 19,000,000 16,000,000 45,000,000 27,000,000 11,000,000 13,000,000 13,000,000 12,000,000 15,000,000 22,200,000 18,900,000 8,800,000 38,900,000 19,600,000 12,700,000 6,800,000 11,000,000 9,600,000 14,800,000 15,600,000 300,000 100,000 7,900,000 14,000,000 6,100,000 8,800,000 10,900,000 10,400,000 10,200,000 10,000,000 10,000,000 10,300,000 5,600,000 8,200,000 9,900,000 
          non-cash purchase of property, equipment, and other productive assets
        		18,000,000  -8,000,000 0 21,000,000                                   
          adjustments to reconcile net earnings to net cash from operations:
        		                                       
          amortization of debt financing costs
        		                                       
          non-cash restructuring charges
        		 0 0   0 11,000,000                                 
          impairment charges and loss/gain on sale of assets
        		 2,000,000                                      
          benefit for deferred income taxes
        		            -8,000,000   -10,600,000 5,400,000 2,700,000                      
          pension settlement charges
        		 0 9,000,000                                     
          other operating activities
        		                                       
          decrease (increase) in trade receivables
        		                                       
          decrease (increase) in inventories
        		                                       
          increase in accounts payable
        		         71,000,000 -37,000,000 9,000,000 -6,000,000 13,400,000 13,400,000  29,900,000                       
          other assets/accrued liabilities, net - current and non-current
        		                         -15,600,000 -60,500,000 33,300,000 37,000,000 0 -23,600,000         
          acquisition of property and equipment
        		                                       
          proceeds from maturity (purchases) of marketable securities
        		                                       
          settlement on sale of subsidiaries
        		           0 -3,000,000                           
          payment for acquisitions, net of cash acquired
        		     0 0   -166,000,000 -13,000,000 -994,000,000 -26,000,000 100,000 -14,800,000  -379,700,000 -10,700,000 -10,700,000 -1,163,500,000 0 0 -127,500,000 0 0    -84,200,000 1,200,000 -86,900,000         
          proceeds from borrowings
        		 140,000,000 245,000,000       0 0                             
          payments related to financing obligations
        		                                       
          dividends paid
        		         0 0 0 -4,000,000 -4,300,000 -13,000,000 -8,100,000 -28,100,000 -20,000,000 -11,900,000                     
          cash paid, in lieu of equity, for tax withholding obligation
        		                                       
          effect of foreign currency on cash
        		                       -20,300,000 9,400,000 -600,000 9,100,000 6,000,000 7,900,000 -9,900,000 900,000 -2,600,000 0 -2,600,000 -1,300,000 2,100,000 -4,800,000 -3,300,000 -13,600,000 
          net increase in cash and equivalents
        		                                       
          cash and equivalents at beginning of period
        		              953,200,000 953,200,000 345,400,000 345,400,000 345,400,000 0 0 0 410,200,000 0 0 0 288,300,000 0 0 0 131,600,000 0 0 0 151,300,000 0 0 0 74,400,000 
          cash and equivalents at end of period
        		              833,100,000 1,007,000,000 608,400,000 188,900,000 243,400,000 117,500,000 20,000,000 -58,200,000 266,100,000 18,700,000 62,000,000 -271,900,000 601,400,000 47,100,000 -14,600,000 123,700,000 132,100,000 -2,300,000 18,400,000 -35,900,000 151,400,000 35,200,000 32,000,000 20,900,000 63,200,000 
          supplementary disclosure of non-cash investing and financing activity:
        		                                       
          issuance of common stock from partial conversion of redeemable preferred stock
        		                                       
          non-cash purchase of property, equipment
        		                                       
          fiscal year ended june 30, 2024
        		                                       
          manufacturing & commercial product supply
        		              124,400,000 89,900,000 217,600,000 245,000,000 242,000,000                     
          development services & clinical supply
        		                                       
          total
        		              403,900,000 377,100,000 242,300,000 267,900,000 263,700,000                     
          inter-segment revenue elimination
        		                                       
          combined net revenue
        		                                       
          adjustments to reconcile net income to net cash from operating activities:
        		                                       
          non-cash foreign currency transaction gain
        		          0     -3,800,000                        
          proceeds from maturity of marketable securities
        		           -16,000,000 20,000,000                           
          net decrease in cash and cash equivalents
        		  -67,000,000 20,000,000 -71,000,000  -190,000,000                                 
          non-cash foreign currency transaction loss
        		   2,000,000 9,000,000   -26,000,000 27,000,000        2,500,000 5,500,000                      
          (payment) proceeds for investments
        		    -1,000,000                                   
          financing-related charges
        		          0 0 4,000,000                           
          gain on derivative instrument
        		         0 0 0 -2,000,000  -16,000,000   -1,400,000                      
          (settlement on) proceeds from sale of subsidiaries
        		         0                              
          payment made for investments
        		         2,000,000 -1,000,000 1,000,000 -4,000,000 -26,900,000 -1,000,000 -1,600,000 -2,400,000 -2,000,000 -700,000 -500,000                    
          proceeds from sale of common stock
        		             200,000 81,800,000 83,600,000 494,200,000   200,000 -200,000 0 445,500,000 0 0               
          net decrease in cash and equivalents
        		              -120,100,000                         
          note receivable from sale of blow-fill-seal business
        		                                       
          fiscal year ended june 30, 2023
        		                                       
          (benefit from) benefit from deferred income taxes
        		              -5,300,000                         
          proceeds from maturity of (purchase of) marketable securities
        		                                       
          cash paid, in lieu of equity, for tax-withholding obligations
        		          0 -5,000,000 -4,000,000  -26,400,000 -19,600,000 -25,300,000 -24,400,000 -18,100,000  -2,300,000 -5,900,000 -5,100,000                 
          proceeds from sale of marketable securities
        		       37,000,000 24,000,000                               
          proceeds from (payment for) investments
        		        3,000,000                               
          cash received (paid), in lieu of equity, for tax-withholding obligations
        		        2,000,000                               
          non-cash foreign currency transaction losses (gains)
        		                                       
          amortization and write-off of debt financing costs
        		              3,300,000 1,700,000 10,700,000 3,100,000 1,500,000 7,100,000 1,000,000 900,000 5,200,000 1,100,000                
          asset impairments charges and gain/loss on sale of assets
        		                                       
          (gain) loss on sale of subsidiary
        		             2,000,000                          
          financing related charges
        		                                       
          increase in trade receivables
        		             -184,800,000                          
          cash flows from investing activities:
        		                                       
          acquisition of property and equipment and other productive assets
        		                   -88,800,000 -48,000,000 -43,000,000 -38,300,000 -58,800,000 -34,800,000 -40,200,000 -42,700,000 -52,000,000 -33,700,000 -26,400,000 -27,700,000 -31,800,000 -25,300,000 -49,300,000 -33,200,000 -32,300,000 -37,400,000 -40,100,000 -31,200,000 
          purchases of marketable securities
        		         5,000,000    2,900,000                          
          fiscal year ended june 30, 2022
        		                                       
          development services
        		              279,500,000 287,200,000 24,700,000 22,900,000 21,700,000                     
          clinical supply services
        		                                       
          impairments charges and gain on sale of assets
        		          2,000,000                             
          impairments charges and (gain) loss on sale of assets
        		            3,000,000                           
          net change in other borrowings
        		             400,000 1,500,000 -3,900,000 -45,200,000 -5,900,000 -2,500,000 -1,900,000 -1,600,000 -400,000 -4,500,000 -500,000 -2,000,000 1,100,000 -1,700,000 100,000 -300,000 -1,300,000 -4,300,000         
          non-cash foreign currency transaction (gains) losses
        		                                       
          asset impairments charges and (gain) loss on sale of assets
        		              2,400,000                         
          proceeds from sale of subsidiaries
        		             200,000   20,800,000 20,800,000      0 0               
          proceeds from sale of preferred stock
        		                                       
          fiscal year ended june 30, 2021
        		                                       
          (gain) loss on derivative instrument
        		                                       
          prepayment for pending business acquisition
        		                 -55,100,000                      
          effect of foreign currency exchange on cash
        		              17,800,000 5,700,000 -10,500,000 -1,400,000 -6,500,000  2,300,000 -3,500,000 -700,000                 
          three months ended december 31, 2020
        		                                       
          adjustments to reconcile earnings from operations to net cash from operations:
        		                                       
          asset impairments charges and /loss on sale of assets
        		               1,800,000 2,100,000 1,500,000                      
          (gain) / loss on derivative instrument
        		               -9,000,000                        
          equity compensation
        		               18,700,000 35,500,000 26,900,000 16,600,000     6,100,000 5,600,000 8,500,000 7,000,000 4,500,000 4,600,000 4,900,000 6,900,000 2,300,000 3,400,000 2,600,000 2,500,000 2,600,000 2,100,000 2,800,000 1,500,000 
          (increase)/decrease in inventories
        		               -65,400,000                        
          increase/(decrease) in accounts payable
        		               6,600,000   -47,300,000  17,200,000 7,000,000 -18,300,000 17,000,000 15,700,000 -2,400,000 2,000,000 22,300,000 2,200,000 -13,400,000 -1,200,000 14,800,000 1,200,000 3,800,000 1,600,000 2,300,000 7,500,000 4,800,000 -26,300,000 
          net cash provided by/(used in) financing activities
        		               49,600,000             -7,300,000 109,800,000 65,900,000         
          net increase/(decrease) in cash and equivalents
        		               53,800,000 263,000,000 -156,500,000 -102,000,000 117,500,000 20,000,000 -58,200,000 -144,100,000 18,700,000 62,000,000 -271,900,000 313,100,000 47,100,000 -14,600,000 123,700,000 500,000 -2,300,000 18,400,000 -35,900,000 100,000 35,200,000 32,000,000 20,900,000 -11,200,000 
          three months ended september 30, 2020
        		                                       
          non-cash foreign currency transaction (gains)/losses
        		                                       
          asset impairments charges and (gain)/loss on sale of assets
        		                  -200,000 2,400,000 -100,000 -100,000 2,900,000                 
          reclassification of financing fees paid
        		                       0 0               
          (gain)/loss on derivative instrument
        		                  8,900,000                     
          provision/(benefit) for deferred income taxes
        		                  -600,000 -14,400,000 -600,000 -1,300,000 1,200,000 -4,900,000 4,700,000 37,400,000 -1,800,000 -2,100,000 -100,000 5,000,000 -4,100,000 -18,700,000 2,900,000 1,700,000 -1,200,000 -93,700,000 -1,300,000 -18,000,000 -7,700,000 
          (increase) in trade receivables
        		                                       
          (increase) in inventories
        		                                       
          net cash (used in) investing activities
        		                -664,800,000 -199,200,000 -84,900,000 -1,252,700,000 -48,900,000 -43,000,000 -165,800,000 -58,800,000 -34,800,000 -783,000,000 -42,700,000             
          fiscal year ended june 30, 2020
        		                                       
          call premium on debt redemption
        		                10,000,000                       
          loss on derivative instrument
        		                24,900,000                       
          decrease/(increase) in trade receivables
        		                -15,500,000  34,100,000  -29,700,000 -70,600,000 73,700,000  -71,000,000 17,600,000 87,000,000  -15,100,000 -2,500,000 43,900,000  -9,000,000 -30,000,000 59,700,000 -52,100,000 -5,200,000 -12,200,000 62,000,000 
          decrease/(increase) in inventories
        		                -54,700,000 -11,600,000 200,000  -17,100,000 -5,000,000 -21,000,000    -7,300,000  -2,300,000 -1,500,000 -16,400,000  -7,300,000 -16,000,000 -20,400,000 10,700,000 -4,700,000 -11,100,000 -14,100,000 
          net cash (used in)/provided by financing activities
        		                670,700,000 -101,800,000 -35,800,000  -8,700,000 -55,000,000 -18,800,000         -3,700,000 -6,200,000 -10,600,000 -10,300,000 -12,500,000 -13,600,000 135,700,000 86,900,000 
          three months ended march 31, 2020
        		                                       
          three months ended december 31, 2019
        		                                       
          net earnings/
        		                  100,000  -2,900,000 49,000,000 -14,400,000            8,900,000 153,400,000 30,800,000 46,000,000 -19,900,000 
          non-cash foreign currency transaction (gain)/loss
        		                  -100,000  -4,900,000 1,200,000 2,000,000  7,200,000 -1,200,000 8,300,000  9,100,000 -2,700,000 -700,000  -1,600,000 -3,500,000 -100,000  -2,400,000 -1,200,000 -11,200,000 
          three months ended september 30, 2019
        		                                       
          net revenue
        		                    -5,500,000                   
          cost of sales
        		                    -2,800,000                   
          gross margin
        		                    -2,700,000                   
          earnings from operations before income taxes
        		                                       
          income tax expense
        		                    8,600,000                   
          other assets/accrued liabilities, net — current and non-current
        		                    -700,000 -2,200,000 -55,800,000                 
          earnings from continuing operations before income taxes
        		                    -8,700,000                   
          adjustments to reconcile earnings/(loss) from operations to net cash from operations:
        		                                       
          1.
        		                                       
          adjustments to reconcile earnings from continued operations to net cash from operations:
        		                                       
          (increase)/decrease in trade receivables
        		                                       
          purchase of redeemable non-controlling interest shares
        		                                       
          asset impairments and (gain)/loss on sale of assets
        		                        200,000    1,800,000   1,900,000 -300,000 -100,000 1,200,000 900,000 300,000   
          amortization and write off of debt financing costs
        		                         1,200,000 1,300,000 1,200,000 1,300,000 3,200,000 1,100,000 1,300,000 1,100,000 1,200,000 1,100,000 1,200,000 1,000,000 1,400,000 12,400,000 
          cash paid, in lieu of equity, for tax withholding obligations
        		                         -4,000,000 -8,400,000  -2,300,000 -400,000 -100,000  -2,400,000 0 -5,600,000     
          equity offering, sale of common stock
        		                          277,800,000             
          net earnings/(loss) from discontinued operations
        		                                   -100,000 0 -200,000 400,000 
          earnings from continuing operations
        		                              4,600,000 61,900,000 9,800,000       
          adjustments to reconcile (loss)/earnings from continued operations to net cash from operations:
        		                                       
          impairments charges and (gain)/loss on sale of assets
        		                                       
          non-cash gain on acquisition
        		                                   1,300,000 0 -3,200,000 -7,000,000 
          call premium and financing fees paid
        		                                       
          net cash provided by/(used in) operating activities from continuing operations
        		                              48,300,000 33,900,000 49,900,000 26,600,000 44,900,000 77,200,000 94,300,000 40,400,000 -40,200,000 
          net cash provided by/(used in) operating activities from discontinued operations
        		                                   -100,000 0 -200,000 400,000 
          net cash provided by/(used in) operating activities
        		                             47,700,000 48,300,000 33,900,000 49,900,000 26,600,000 44,900,000 77,100,000 94,300,000 40,200,000 -39,800,000 
          payment for acquisitions
        		                                   800,000 -6,500,000 -111,600,000 -13,500,000 
          net cash provided by/(used in) investing activities
        		                             -23,900,000 -114,600,000 -29,900,000 -25,300,000 -49,300,000 -33,200,000 -31,500,000 -43,900,000 -151,700,000 -44,700,000 
          purchase of redeemable noncontrolling interest shares
        		                               0 0       
          equity contribution
        		                                       
          net cash (used in)/provided by investing activities
        		                                       
          net cash provided by/(used in) investing activities from continuing operations
        		                                  -33,200,000 -31,500,000 -43,900,000 -151,700,000 -44,700,000 
          net cash provided by/(used in) investing activities from discontinued operations
        		                                       
          net cash (used in)/provided by financing activities from continuing operations
        		                                  -10,300,000 -12,500,000 -13,600,000 135,700,000 86,900,000 
          net cash (used in)/provided by financing activities from discontinued operations
        		                                       
          reclassification of call premium payments and financing fees paid
        		                                    0 2,800,000 9,800,000 
          other accrued liabilities and operating items
        		                                13,800,000 -5,100,000 -44,800,000 12,700,000 29,500,000 -16,100,000 -76,000,000 
          net change in short-term borrowings
        		                                800,000    -1,200,000 -5,700,000 11,700,000 
          equity contribution/
        		                                    0 0 948,800,000 
          earnings/(loss) from continuing operations
        		                                  8,900,000 153,500,000 30,800,000 46,200,000 -20,300,000 
          share settlement
        		                                       
          balance at june 30, 2014
        		                                     0 891,800,000 
          additions/
        		                                       
          foreign currency translation adjustments
        		                                     -29,200,000 -32,000,000 
          balance at december 31, 2014
        		                                       
          balance at september 30, 2014
        		                                      859,800,000 
          proceeds from insurance related to long lived assets
        		                                       
          payments related to revolver credit facility fees
        		                                       
          distribution to noncontrolling interest holder